Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.7M
-
Number of holders
-
210
-
Total 13F shares, excl. options
-
21.8M
-
Shares change
-
-37.1K
-
Total reported value, excl. options
-
$2.6B
-
Value change
-
-$32.8M
-
Put/Call ratio
-
0.71
-
Number of buys
-
94
-
Number of sells
-
-117
-
Price
-
$119.01
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q3 2023
264 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q3 2023.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 210 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 21.8M shares
of 24.7M outstanding shares and own 88.43% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.52M shares), T. Rowe Price Investment Management, Inc. (2.32M shares), VANGUARD GROUP INC (2.13M shares), BlackRock Inc. (1.73M shares), WELLINGTON MANAGEMENT GROUP LLP (1.59M shares), FMR LLC (1.12M shares), FULLER & THALER ASSET MANAGEMENT, INC. (1.02M shares), JPMORGAN CHASE & CO (728K shares), MORGAN STANLEY (652K shares), and VICTORY CAPITAL MANAGEMENT INC (632K shares).
This table shows the top 210 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.